Navigation Links
SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
Date:9/5/2008

SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswire-FirstCall/ -- SARcode Corporation, a private company focused on small molecule LFA-1 inhibitors to treat inflammatory diseases, and Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced SARcode's initiation of a Phase 1 clinical trial of a small molecule LFA-1 product candidate for T-cell mediated ophthalmic diseases. Sunesis and SARcode entered into a license agreement providing SARcode with an exclusive license to Sunesis' LFA-1 technology to develop LFA-1 inhibitors in March 2006.

"LFA-1 antagonists mediate both migration and adhesion of the white blood cells to sites of inflammation as part of the body's immune response," said Tom Gadek, Ph.D., chief executive officer of SARcode Corporation. "Lead indications for LFA-1 include dry eye and allergic conjunctivitis, both large indications with unmet medical needs. The results of this study will inform dose selection for several Phase 2 studies to commence in the first half of 2009."

"We congratulate SARcode on the progress they have made moving this program forward into the clinic," said Daniel Swisher, chief executive officer and president of Sunesis. "The LFA-1 inhibitor product candidate, which was discovered at Sunesis, has the potential to address immunological and inflammatory diseases, including dry eye syndrome. We look forward to SARcode's continued advancement of this novel compound."

As part of the license agreement, Sunesis has earned a milestone payment from SARcode of $500,000 and a $375,000 convertible note. The next payable milestone, if earned, will be for initiation of the Phase 2 clinical program.

About SARcode

SARcode is a privately-held biopharmaceutical company focused on the development of best in class small molecule LFA-1 antagonists as novel nonsteroidal immunomodulators/ anti-inflammatory agents for the treatment of T-cell mediated inflammatory diseases.

About Sunesis Pharmaceuticals <
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
2. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
3. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
4. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
5. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
6. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
7. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
8. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
9. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
10. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
11. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... --  Long Beach dentist , Dr. Rassouli, is now offering ... in tooth replacement because they offer the closest match to ... and preserve smiles and improve overall dental health. Dr. Rassouli ... as a part of a smile makeover or full mouth ... smile. The loss of a tooth can lead ...
(Date:11/22/2014)... , Nov. 21, 2014 Many power ... the growing influence of patients in the biopharmaceutical ... interactions. Now, more than ever, understanding how to ... medical products is essential. According ... LLC, benchmarked companies spent about two-thirds of their ...
(Date:11/21/2014)... Calif. , Nov. 21, 2014 In ... and Performance Scrubs carried out a new product development ... industry,s very first "limited edition" lab coat , ... female professors of surgery in the world. The new ... its unisex predecessors, with a sleek envelope collar, vertical ...
Breaking Medicine Technology:Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2
... DIEGO, Nov. 11, 2010 Althea Technologies, Inc., a ... biopharmaceutical and parenteral products, announced today that Rick ...  Mr. Hancock brings twenty-seven years of industry experience and ... company into the future.  Mr. Hancock will lead the ...
... a meeting convened by the U.S. Food and Drug ... took the next step in advancing efforts toward the ... to ensure the safe and effective testing of artificial ... today,s meeting there was a strong consensus among leading ...
Cached Medicine Technology:Althea Technologies Announces Appointment of Rick Hancock as President 2JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 2JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 3JDRF Clinical Panel Recommends Next Steps for Artificial Pancreas Clinical Testing 4
(Date:11/22/2014)... Cancer researchers in New York and ... communication tunnels and the growth and spread of mesothelioma. ... on the Surviving Mesothelioma website. , Doctors at ... Minnesota have just released their study on tunneling nanotubes ... cells. They found that mesothelioma cells contain ...
(Date:11/22/2014)... black prom dress will never go out of fashion. BellasDress.com, ... new items of black prom gowns . Now all ... up to 70% off. People throughout the world can enjoy ... made with the best materials, can make wearers feel comfortable. ... company provides these beautiful outfits in a huge range of ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in ... dresses; the business offers a wide range of special ... worldwide, allowing them to create multiple looks easily. , ... new collection of chic wedding dresses has been prepared ... at discounted rates now. Dylan Queen can always create ...
(Date:11/22/2014)... 2014 Discount-Dress.com is an important ... firm is to increase the company’s online market share by ... selection of bridesmaid dresses and announced a bridesmaid dress promotion ... until Dec. 30, 2014. All the dresses from this company ... , In fact, Discount-Dress.com is very good at manufacturing wedding ...
(Date:11/22/2014)... 2014 "My friend went in for ... the machine," said an inventor from Cambria Heights, N.Y. ... back a second time because the first results were ... developed the patent-pending MAMO EASY to offer a more ... saves the patient from the pain normally involved with ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2
... and external ... pediatric heart pumps, PITTSBURGH, April 3, ... in the use of lifesaving,ventricular assist devices (VADs) for children in ... awarded a $2.3 million grant from,the National Institutes of Health (NIH) ...
... Angeles Focuses on the Impact of the ... Environment on Public Health, LOS ANGELES, April ... off National Public Health Week today,with a press conference held outside the ... "Healthy People:,Healthy Planet - Climate Change in LA". It focuses on the ...
... M. Bradley Receives Top Recognition as Titan of Business & ... ... WASHINGTON, April 3, 2008 Washington DC,business community leaders ... Leukemia Ball. Drawing over 2,500 guests,to the Washington Convention Center ...
... YORK (April 3, 2008) -- Dr. John A. Clements ... recognition of his seminal contributions to our understanding of ... a lifesaving treatment for respiratory distress syndrome (RDS) in ... neonatal RDS now causes very few deaths. , The ...
... 2008 Although sexual dysfunction in some men is ... examined in women. In an article published in the ... researchers found no increased prevalence or incidence of cardiovascular ... dissatisfied with their sexual activity. , Researchers from Boston ...
... The American Heart Associations Los Angeles Division today ... the paramedic model in use around the country and ... Research Institute at Harbor-UCLA Medical Center (LA BioMed). , ... Awards to Dr. Criley and William Koenig, Los Angeles ...
Cached Medicine News:Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 2Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 3Health News:Healthy People: Healthy Planet - Climate Change in LA 2Health News:Healthy People: Healthy Planet - Climate Change in LA 3Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 2Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 3Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 4Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 2Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 4Health News:Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease 2Health News:Pioneer of paramedic model to be honored 2Health News:Pioneer of paramedic model to be honored 3
Graether Collar Button micro iris retractor....
... multi-action solution is the first and only ... cleans, disinfects and conditions gas permeable contact ... cleaning comparable to the leading two-bottle GP ... provides comfort upon insertion by enveloping the ...
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements....
... Lifestyle Gp is a simultaneous ... back surface. Through a series ... curves, the LifeStyle Gp delivers ... add. Plus, its multi-aspheric center-distance ...
Medicine Products: